Clinical Trial

Precision Medicine for Indolent Systemic Mastocytosis (PRISM)

Name: Precision Medicine for Indolent Systemic Mastocytosis (PRISM) — clinical trial record (NCT07757893)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: PRISM

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

This study is being done to better understand how symptoms of Systemic Mastocytosis (SM) relate to biological signals and to better understand how different treatments affect these signals.

Trial Details

NCT Number	NCT07757893
Lead Sponsor	Mayo Clinic
Conditions	Systemic Mastocytosis
Enrollment	25 participants
Start Date	2026-09-09
Primary Completion	2027-08-31 (estimated)
Study Completion	2027-08-31 (estimated)
Updated on ClinicalTrials.gov	2026-08-11